Cystic Fibrosis Patient Registries: Domestic and Foreign Experience
Cystic fibrosis is a multi-organ genetic disease that reduces life expectancy and requires costly complex therapy. The economic burden of cystic fibrosis is determined by the cost of treatment, the conditions for optimizing medical technologies based on epidemiological knowledge of the disease cours...
Saved in:
| Main Authors: | Dmitry A. Andreev, Ekaterina E. Bashlakova, Natalia V. Khachanova, Maria V. Davydovskaia |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2017-08-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1512 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Status of Cystic Fibrosis in Türkiye: Data from the National Registry
by: Dilber Ademhan Tural, et al.
Published: (2025-09-01) -
Evaluation of Cystic Fibrosis Newborn Screening and Follow-Up Process in Georgia (2022–2023)
by: Nino Vardosanidze, et al.
Published: (2025-06-01) -
Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis
by: Mathew P. Estey, et al.
Published: (2025-12-01) -
Interest of Colchicine for the Treatment of Cystic Fibrosis Patients. Preliminary Report
by: I. Sermet-Gaudelus, et al.
Published: (1999-01-01) -
Prevalence and Characteristics of Patients with Cystic Fibrosis-Related Diabetes in Croatia
by: Lora Stanka Kirigin Biloš, et al.
Published: (2025-05-01)